Identification of mitochondria-related biomarkers for acute respiratory distress syndrome

Huang Hongyuan1,2, Chen Mengchi3, Liang Yingying1

  • 1The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, Guangxi, China.

Scientific Reports
|August 2, 2025
PubMed

Insights

Mitochondria-related genes (MRGs) show promise as biomarkers for acute respiratory distress syndrome (ARDS). SLC2A1 and IFI27 are identified as novel diagnostic biomarkers for ARDS, aiding in treatment strategies.

Area of Science:

  • Molecular biology
  • Immunology
  • Genetics

Background:

  • Mitochondria-related genes (MRGs) are crucial for cellular functions and disease processes.
  • The specific role of MRGs in acute respiratory distress syndrome (ARDS) requires further elucidation.
  • Identifying reliable biomarkers is essential for early diagnosis and effective treatment of ARDS.

Purpose of the Study:

  • To identify novel mitochondria-related gene (MRG)-based biomarkers for acute respiratory distress syndrome (ARDS).
  • To investigate the role of specific immune cell types in ARDS pathogenesis.
  • To explore the diagnostic potential of identified biomarkers in sepsis-induced ARDS.

Main Methods:

  • Differential gene expression analysis comparing sepsis-ARDS and sepsis-non-ARDS groups.
  • Intersection of mitochondria-related genes (MRGs) with differentially expressed genes (DEGs).
  • Bioinformatic analysis to identify key cell types and biomarkers, including immune cell profiling.

Main Results:

  • Twenty MRG-related DEGs were identified, enriched in mitochondrion-related pathways.
  • SLC2A1 and IFI27 were identified as potential diagnostic biomarkers for ARDS.
  • Monocytes, particularly CD14+ subtypes, and B cells showed differential expression in sepsis-ARDS patients. IFI27 and SLC2A1 were upregulated in CD14 monocytes of ARDS patients.

Conclusions:

  • SLC2A1 and IFI27 are novel, promising MRG-related diagnostic biomarkers for ARDS.
  • These findings offer a theoretical basis for developing new therapeutic strategies for ARDS.
  • The study highlights the importance of immune cell dynamics, especially monocytes, in ARDS pathophysiology.